Article detail · 2023 · article
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study
Journal
Journal of Geriatric Oncology
ISSN1879-4068
YÖKSİS
OpenAlex
Open access · green
Year2023
Citations13OpenAlex
Citations10Semantic Scholar
Percentile%88.5
FWCI2.11.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q2
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueJournal of Geriatric Oncology
- Catalog match (ISSN)Journal of Geriatric Oncology
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
- Semantic Scholarcitation count (not merged with OpenAlex)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
13citationsOpenAlex · cited_by_count (cache / database)
5 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2025 Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort StudyCitations 2 · OpenAlex
- 2024 Concomitant Use of Proton Pump Inhibitors and CDK4/6 inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real World Cohort StudyCitations 2 · OpenAlex
- 2024 Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort StudyCitations 2 · OpenAlex
- 2026 Safe use of ribociclib in a patient with HR+/HER2− metastatic breast cancer receiving chronic hemodialysisCitations 1 · OpenAlex
- 2026 Safe use of ribociclib in a patient with HR+/HER2− metastatic breast cancer receiving chronic hemodialysisCitations 1 · OpenAlex